top of page

Solas BioVentures to Seek Up to $100M for Second Early-Stage Fund

SEPT 2, 2016

Learn More

Drug Developer Arrivo BioVentures Launches With $49M 

MAY 25, 2016

Learn More

CardioNXT Secures Additional $1.5M Funding From Solas BioVentures To Drive Atrial Fibrillation Treatment Innovation

MAY 24, 2016

Learn More
New transparent.png
Solas - White - Logo.png

LINKEDIN

Headquarters
412 Georgia Avenue
Suite 201

Chattanooga, TN 37403

Office
8 Davis Drive

RTP, NC 27709

©2020 by Solas BioVentures. 

bottom of page